Found: 15
Select item for more details and to access through your institution.
To prevent SARS‐CoV‐2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?
- Published in:
- Indoor Air, 2021, v. 31, n. 5, p. 1295, doi. 10.1111/ina.12870
- By:
- Publication type:
- Article
Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 262, doi. 10.3390/antibiotics13030262
- By:
- Publication type:
- Article
Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 6, p. 746, doi. 10.3390/antibiotics11060746
- By:
- Publication type:
- Article
Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 704, doi. 10.3390/vaccines12070704
- By:
- Publication type:
- Article
Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.803763
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Intranasal or Intratesticular Route Induces Testicular Damage.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e974, doi. 10.1093/cid/ciac142
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e905, doi. 10.1093/cid/ciab1062
- By:
- Publication type:
- Article
Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 11, p. 1933, doi. 10.1093/cid/ciab707
- By:
- Publication type:
- Article
False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 8, p. 1485, doi. 10.1093/cid/ciab684
- By:
- Publication type:
- Article
Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 Virus Variant With Novel Genomic Architecture in Hong Kong.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. 1696, doi. 10.1093/cid/ciab198
- By:
- Publication type:
- Article
Nosocomial Outbreak of Coronavirus Disease 2019 by Possible Airborne Transmission Leading to a Superspreading Event.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. e1356, doi. 10.1093/cid/ciab313
- By:
- Publication type:
- Article
Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. e719, doi. 10.1093/cid/ciab083
- By:
- Publication type:
- Article
Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 11, p. 2939, doi. 10.1093/cid/ciaa797
- By:
- Publication type:
- Article
Consistent Detection of 2019 Novel Coronavirus in Saliva.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 15, p. 841, doi. 10.1093/cid/ciaa149
- By:
- Publication type:
- Article